Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M55,647Revenue $M20,405Net Margin (%)21.7Altman Z-Score3.3
Enterprise Value $M57,971EPS $3.0Operating Margin %14.1Piotroski F-Score7
P/E(ttm)12.3Beneish M-Score-2.6Pre-tax Margin (%)15.6Higher ROA y-yY
Price/Book2.610-y EBITDA Growth Rate %-3.0Quick Ratio1.5Cash flow > EarningsN
Price/Sales3.65-y EBITDA Growth Rate %-19.5Current Ratio1.8Lower Leverage y-yN
Price/Free Cash Flow25.1y-y EBITDA Growth Rate %22.1ROA % (ttm)12.5Higher Current Ratio y-yY
Dividend Yield %2.7PEG--ROE % (ttm)24.0Less Shares Outstanding y-yY
Payout Ratio %56.0Shares Outstanding M1,492ROIC % (ttm)12.2Gross Margin Increase y-yY

Gurus Latest Trades with ABT

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ABTVanguard Health Care Fund 2015-12-31 Reduce-0.08%$39.89 - $46.05
($44.24)
$ 36.87-17%Reduce -13.14%6,027,260
ABTRichard Pzena 2015-12-31 Reduce-0.08%$39.89 - $46.05
($44.24)
$ 36.87-17%Reduce -6.31%4,861,129
ABTKen Fisher 2015-12-31 Add$39.89 - $46.05
($44.21)
$ 36.87-17%Add 13.32%17,286
ABTRichard Pzena 2015-09-30 Reduce-0.32%$39.06 - $51.2
($47.14)
$ 36.87-22%Reduce -18.17%5,188,346
ABTJoel Greenblatt 2015-09-30 Add0.16%$39.06 - $51.2
($47.14)
$ 36.87-22%Add 39.49%1,455,289
ABTRobert Olstein 2015-09-30 Add0.09%$39.06 - $51.2
($47.14)
$ 36.87-22%Add 10.69%176,000
ABTGeorge Soros 2015-09-30 Add0.09%$39.06 - $51.2
($47.14)
$ 36.87-22%Add 21.47%731,481
ABTFirst Eagle Investment 2015-09-30 Add0.09%$39.06 - $51.2
($47.14)
$ 36.87-22%Add 15.36%6,825,289
ABTVanguard Health Care Fund 2015-09-30 Reduce-0.06%$39.06 - $51.2
($47.14)
$ 36.87-22%Reduce -8.60%6,938,700
ABTMario Gabelli 2015-09-30 Reduce-0.01%$39.06 - $51.2
($47.14)
$ 36.87-22%Reduce -71.12%17,625
ABTDodge & Cox 2015-09-30 Reduce$39.06 - $51.2
($47.14)
$ 36.87-22%Reduce -3.20%30,268
ABTKen Fisher 2015-09-30 Add$39.06 - $51.2
($47.14)
$ 36.87-22%Add 1.73%15,254
ABTJoel Greenblatt 2015-06-30 Add0.41%$45.89 - $50.03
($47.99)
$ 36.87-23%Add 2409.54%1,043,293
ABTRobert Olstein 2015-06-30 Reduce-0.1%$45.89 - $50.03
($47.99)
$ 36.87-23%Reduce -11.17%159,000
ABTFirst Eagle Investment 2015-06-30 Add0.09%$45.89 - $50.03
($47.99)
$ 36.87-23%Add 15.05%5,916,570
ABTRichard Pzena 2015-06-30 Reduce-0.01%$45.89 - $50.03
($47.99)
$ 36.87-23%Reduce -0.53%6,340,115
ABTDodge & Cox 2015-06-30 Reduce$45.89 - $50.03
($47.99)
$ 36.87-23%Reduce -2.49%31,268
ABTKen Fisher 2015-06-30 Add$45.89 - $50.03
($47.99)
$ 36.87-23%Add 14.50%14,994
ABTMario Gabelli 2015-06-30 Reduce$45.89 - $50.03
($47.99)
$ 36.87-23%Reduce -6.52%61,032
ABTMason Hawkins 2015-03-31 Sold Out -2.3%$43.41 - $47.83
($45.92)
$ 36.87-20%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ABT is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ABT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
WHITE MILES DChairman and CEO 2015-12-16Sell438,000$46-18.67view
Salvadori Daniel Gesua SiveSenior Vice President 2015-09-28Sell815$39.65-5.65view
Fussell Stephen RExecutive Vice President 2015-08-18Sell13,096$50.46-25.86view
Blaser Brian JExecutive Vice President 2015-07-28Sell11,300$50.96-26.59view
Pavee Jean-YvesSenior Vice President 2015-06-03Sell10,500$49-23.65view
Mason Heather LExecutive Vice President 2015-04-27Sell13,500$47.45-21.16view
BIRD ROGERSenior Vice President 2015-04-27Sell28,548$47.57-21.36view
Contreras JaimeSenior Vice President 2015-03-31Sell228$46.43-19.43view
White J. ScottSenior Vice President 2015-03-26Sell12,483$46.68-19.86view
Warmuth Michael JExecutive Vice President 2015-03-10Sell13,500$46.41-19.39view

Press Releases about ABT :

Quarterly/Annual Reports about ABT:

    News about ABT:

    Articles On GuruFocus.com
    Valeant's Share Price Continues to Decline Feb 05 2016 
    Abbott a Dividend Aristocrat Stock Propelled by Emerging Markets Dec 11 2015 
    Baxalta Vs. AbbVie: Biopharma Spin-Off Battle Aug 20 2015 
    Profit from Emerging Market Health Care Growth With Abbott Laboratories Jul 25 2015 
    Becton and Dickinson: A Long-Term Bet Jul 08 2015 
    Mason Hawkins Comments on Abbott Laboratories May 28 2015 
    Endo International Posts Upbeat Q1 Results May 13 2015 
    How Much Money Will You Need To Retire? Mar 31 2015 
    Top Stock Picks Among Companies That Recently Increased Dividends Mar 09 2015 
    Endo International Shares Upbeat After Positive Q4 Earnings Report Mar 03 2015 

    More From Other Websites
    SHAREHOLDER ALERT: The Law Offices of Vincent Wong Launches an Investigation of the Board of... Feb 04 2016
    ​Alere executives stand to reap $24M in payouts with Abbott buyout Feb 04 2016
    Rationale for the Alere–Abbott Laboratories Merger Feb 04 2016
    Abbott Labs Beefs Up Its Diagnostics Portfolio with Alere Feb 04 2016
    Abbott Laboratories Posts Weak Guidance for 2016 Feb 04 2016
    Abbott Established Pharmaceuticals: Impact of Currency Headwinds Feb 04 2016
    What Makes Abbott Laboratories (ABT) a Strong Sell? Feb 04 2016
    Abbott Stock Has Bear Run after 4Q15 Earnings Release Feb 04 2016
    Children in Europe Now Have Access to First-Of-Its-Kind Diabetes Sensing Technology - Eliminates... Feb 04 2016
    Abbott’s Medical Devices Segment Posts Dismal 4Q15 Revenues Feb 03 2016
    Amid the Market Carnage, Is Now the Right Time to Buy Abbott Laboratories? Feb 03 2016
    Abbott Labs to Boost Diagnostics Business with Alere Buyout Feb 02 2016
    INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Alere Inc. of an Investigation... Feb 02 2016
    The C-Suite Speaks: Business as Usual? Feb 02 2016
    Will Alere (ALR) Stock Be Helped by Possible S&P Upgrade? Feb 02 2016
    Alere Debt May Get Upgrade Thanks to Abbott Merger Feb 02 2016
    ALERE INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC... Feb 02 2016
    This 'Bear-Beating' Health Care Stock Could Soon Soar -- Here's Why Feb 02 2016
    Company News for February 02, 2016 Feb 02 2016
    Growth of Abbott’s Nutrition Segment Driven by Sales Feb 02 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK